QUEBEC CITY, June 26 /CNW Telbec/ - DiagnoCure Inc. (TSX: CUR), a life
sciences company commercializing high-value cancer diagnostic tests and
delivering laboratory services, is actively finalizing the imminent launch of
its new Previstage(TM) GCC Colorectal Cancer Staging Test planned for this
summer, and appoints Mr. Phillip Wells as Vice President, Marketing and
National Sales to drive this launch and commercial growth of the Company.
